Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 13,191

Document Document Title
WO/2016/190383A1
A compound represented by structural formula (A) or (B); a method for producing the compound; a microorganism having an ability of producing the compound represented by the formula (A) or (B); and a compound-containing composition and an...  
WO/2016/181013A1
The invention relates to the use of oligosaccharides as stimulators of plant growth in already germinated plants and to a method for obtaining said oligosaccharides. The invention particularly relates to the use of oligosaccharides compo...  
WO/2016/180818A1
The present invention relates to glycosylating polyphenols via biocatalysis. More specifically the present invention discloses particular mutants of the thermostable sucrose phosphorylase derived from the microorganism Thermoanaerobacter...  
WO/2016/180729A1
Apparatus and methods for reducing biofouling in drink such as beer dispensing equipment are described.  
WO/2016/173425A1
This present invention relates to a glucopyranosyl derivative as sodium dependent glucose cotransporters (SGLTs) inhibitor, preparation processes thereof, and pharmaceutical uses thereof, pharmaceutical compositions containing the compou...  
WO/2016/169288A1
The present invention relates to the field of pharmaceutical chemistry. Disclosed are a new amorphous piceatannol 3'-O-glucoside, preparation method thereof, and pharmaceutical composition containing the same. The amorphous piceatannol 3...  
WO/2016/172615A1
The present invention provides N-acetyl-muramic acid (NAM) derivatives having Formula I, wherein Xa is selected from the group consisting of X1-X59, Ya is selected from the group consisting of H, monophosphate, uridine diphosphate and et...  
WO/2016/164921A1
In various embodiments, the invention provides a radiotracer comprising a positron emitting atom bound to a deoxy sugar moiety. The radiotracer is reversible bound to a caging moiety that prevents or retards tissue uptake of the radiotra...  
WO/2016/161951A1
A phillygenin glucuronic acid derivative represented by general formula (I). In general formula (I), R1=H, R2=CnH2n+1, and R3=CnH2n+1; or R1=CnH2n+1, R2=CnH2n+1, and R3=H; or R1-R2=-CH2-, and R3=CnH2n+1; n=1 to 30. The present invention ...  
WO/2016/164394A1
Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, or condition by inhibiting binding of an E-selectin to an E-selectin ligand are disclosed, For example, E-selectin antagonist therape...  
WO/2016/161377A1
This disclosure relates to the incorporation of amphiphilic guanidinylated aminoglycosides (e.g., neomycin) into liposomal assemblies, which contain entrapped therapeutics. The lysosome is responsible for enzymatically breaking down and ...  
WO/2016/156338A1
The present invention relates to synthetic saccharides of general fornnula (I): V*−[Ux+2−Ux+ 1−Ux]n−V−O−L−NH2 that are related to carbapenem-resistant Kliebsella pneumoniae capsular polysaccharide and conjugates thereof. Sa...  
WO/2016/159537A1
The present invention relates to a phytospingosine derivative generated by a condensation reaction of phytospingosine and maltose or lactose, which is an aldose-based disaccharide, and to a composition containing the same. The phytosping...  
WO/2016/159092A1
In the present invention, an organic acid salt of 4'-epidaunorubicin or a hydrate or a solvate thereof is used as a novel production intermediate, whereby it is possible to efficiently remove 13-dihydroepidaunorubicin and 4'-epifeudomyci...  
WO/2016/155888A1
The present invention relates to novel compounds of the formula I, methods for their preparation and their use for treatment of diseases. The invention discloses the synthesis of levodopa (L-DOPA) esters by coupling polyhydroxy compounds...  
WO/2016/145997A1
Disclosed are a pharmaceutically active sugar molecule and a synthesis method thereof. The sugar molecule has a structure as shown by formula (I) or (II) and can be used for synthesizing a sulfonated sugar molecule, so that it can be fur...  
WO/2016/145478A1
The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of kidney and/or liver disease.  
WO/2016/146941A1
The present invention relates to a new method for producing D-galacturonic derivatives and compositions having the formula (I) directly from pectins or pectin depolymerisation products, and to their use as surface active agents.  
WO/2016/040369A3
Glycosphingolipids (GSLs) compositions and methods for iNKT-independent induction of chemokines are disclosed.  
WO/2016/144175A1
The present invention relates generally to the production of steviol glycosides. Provided is a method for enzymatically providing a modified steviol glycoside, comprising incubating a steviol glycoside substrate in the presence of sucros...  
WO/2016/143939A1
The present invention relates to a production method for a complex of a steviol glycoside and a sparingly soluble material having improved solubility, and to a complex of a steviol glycoside and a sparingly soluble material having improv...  
WO/2016/142529A1
The present invention relates to a galactolipid having the following formula (I): (I) or compositions containing same, for use thereof in healing, in repair, reinforcement and re-equilibration of the skin barrier, in skin hydration and i...  
WO/2016/145164A1
Provided herein are compounds, compositions, and methods having application in the field of enhanced oil recovery (EOR). In particular, the short hydrophobe anionic surfactants as well as aqueous compositions comprising these surfactants...  
WO/2016/145192A1
Compositions and methods of utilizing the same are provided for treating bacterial infections. The compositions comprise acidified nitrite in combination with an iron chelator and an antibiotic. The compositions of the present invention ...  
WO/2016/140355A1
The present invention provides a porous polymer compound having a three dimensional skeleton and pores and/or voids that are partitioned and formed by the three dimensional skeleton, said porous polymer compound being characterized in th...  
WO/2016/141152A1
A rebaudioside D containing sweetening composition exhibiting taste like sugar containing a carrier and rebaudioside D is disclosed. A method of making the rebaudioside D containing sweetening composition; and a method of using the rebau...  
WO/2016/134449A1
A Stevia rebaudiana plant is characterized by Rebaudioside A (RA) content of 6-20% dry weight and total steviol glycosides content of 15-28% dry weight in the leaf. The plant is developed using selective breeding technologies and identif...  
WO/2016/120403A1
The present invention relates to a compound of the general formula (1). wherein the pyranose ring is a-D-galactopyranose, A is selected from The compound of formula (1) is suitable for use in a method for treating a disorder relating to ...  
WO/2016/118932A1
The present disclosure relates to branched and linear chimeric compounds containing both nucleic acid and non-nucleic acid moieties, as well as to polynucleotides. The present disclosure also relates to uses thereof for stimulating an im...  
WO/2016/116335A1
The present invention describes a process for the selective synthesis of N-Fmoc-doxorubicin-14-O-dicarboxylic acid mono ester derivatives starting from N-Fmoc-doxorubicin using lipase enzymes and bis-acyl donor compounds such as dicarbox...  
WO/2016/115048A1
Provided are organic solvent free methods for obtaining compositions comprising one or more rhamnolipids as well as compositions obtainable from said methods.  
WO/2016/110216A1
A method for extracting stilbene compounds comprises the following steps: grinding a medicinal material rich in stilbene compounds such as rheum officinale; extracting the medicinal material with a herbal blitzkrieg extractor for one to ...  
WO/2016/109990A1
Disclosed is a method for catalytic synthesis of salidroside. The method comprises: enabling total acetyl glucose to react with 4-benzyloxy-phenethyl alcohol under the action of a catalyst to obtain 2-(4-benzyloxyphenyl)ethyl-(2,3,4,6-O-...  
WO/2016/109880A1
The invention provides lipid A mimics in which one or both of the sugar residues of a natural lipid A disaccharide backbone has been replaced with an aromatic group. These lipid A mimics may further differ from a natural lipid A molecule...  
WO/2016/112129A1
Various embodiments of the present technology provide compositions and methods for a sweetener composition comprising stevia leaf extract, stevia glycosides, and/or Luo Han Guo fruit extract. The sweetener composition provides enhanced t...  
WO/2016/101733A1
Provided are a phillygenin glucuronic acid derivative as shown in the formula (I), and a preparation method and antiviral use thereof, etc., wherein R is H, Me, Na+, K+, and so on.  
WO/2016/103530A1
Provided are a novel compound having a basic skeleton represented by formula (I) and use of the same as an antioxidant. This compound is derived from 1,5-D-anhydrofructose.  
WO/2016/100689A1
Novel steviol glycoside compounds characterized by a first group of four glucopyranose residues attached via the number 13 carbon (C13) of the steviol moiety and a second group of two or three glucopyranose residues attached via the numb...  
WO/2016/098048A1
The invention relates to a bactericidal or bacteriostatic composition comprising an acetal or a long-chain alkyl hexitane ether, preferably sorbitan, arlitan or mannitan, the user thereof in the treatment or prevention of infections invo...  
WO/2016/098046A1
The invention relates to a bactericidal or bacteriostatic composition comprising a mixture of isomers of monosaccharide alkyl monoacetals or monoethers, the use thereof in the treatment or prevention of infections involving Gram-positive...  
WO/2016/090460A1
A Stevia rebaudiana variety characterized by high levels of Rebaudioside C (RC) is disclosed. The variety comprises from about 3-8% by weight RC in the leaf (leaf content) and from about 10-13% total steviol glycosides content (TSG) in t...  
WO/2016/091399A1
The present invention relates to synthetic saccharides of general formula (I) that are related to Streptococcus pneumoniae serotype 4 capsular polysaccharide and conjugates thereof. Said conjugate and a pharmaceutical composition contain...  
WO/2016/092030A1
A sugar surfactant of formula (I), where R1 is H or an alkyl group comprising 1 to 3 carbon atoms and R2 is a polyhydroxy-hydrocarbyl group comprising a straight hydrocarbyl chain to which at least three hydroxyl groups are directly bond...  
WO/2016/089872A1
Compounds, compositions, and methods for treatment and/or prevention of cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating blood and enhancing retention of t...  
WO/2016/088076A1
The present invention relates to a process for obtaining a mixture of C4­-C8 and C9-C18 alkyl monoethers of a saccharide, comprising: a) a first step of acetalization or trans-acetalization of a saccharide or a mixture of saccharides by...  
WO/2016/086108A1
Novel diterpene glycosides and methods for purifying the same are provided herein. In addition, compositions comprising the novel diterpene glycosides, as well as methods of using the diterpene glycosides are provided. Novel diterpene gl...  
WO/2016/086097A1
A novel diterpene glycoside and methods for preparing and purifying the same are provided herein. In addition, compositions comprising the novel diterpene glycoside, as well as methods of using the diterpene glycoside are provided.  
WO/2016/080850A1
Water dispersible, multivalent ligand-lipid constructs that spontaneously and stably incorporate into membranes are disclosed.  
WO/2016/077126A1
The present invention relates to certain SGLT-2 inhibitors, such as ertugliflozin or a co-crystal or a pharmaceutically acceptable salt thereof, for treating and/or preventing metabolic disorders, such as type 1 or type 2 diabetes mellit...  
WO/2016/070740A1
The present invention discloses a class of a compound shown by general formula (I), a pharmaceutically acceptable salt thereof, an easily hydrolyzed prodrug ester or an isomer thereof, a pharmaceutical composition containing this class o...  

Matches 301 - 350 out of 13,191